Increased microvascular permeability to plasma proteins and neutrophil emigration are hallmarks of innate immunity and key features of numerous inflammatory disorders. Whilst neutrophils can promote microvascular leakage, the impact of vascular permeability on neutrophil trafficking is unknown. Here, through the application of confocal intravital microscopy, we reported that vascular permeability enhancing stimuli caused a significant frequency of neutrophil reverse transendothelial cell migration (rTEM). Furthermore, mice with a selective defect in microvascular permeability enhancement (VEC-Y685F-ki) showed reduced incidence of rTEM. Mechanistically, elevated vascular leakage promoted movement of interstitial chemokines into the blood stream, a response that supported abluminal-toluminal neutrophil TEM. Through development of an in vivo cell labelling method we provided direct evidence for the systemic dissemination of rTEM neutrophils, showed them to exhibit an activated phenotype and capable of trafficking to the lungs where their presence was aligned with regions of vascular injury. Collectively, we demonstrated that increased microvascular leakage reverses the localisation of directional cues across venular walls, thus causing neutrophils engaged in diapedesis to re-enter the systemic circulation. This cascade of events offers a mechanism to explain how local tissue inflammation and vascular permeability can induce downstream pathological effects in remote organs, most notably in the lungs.
Introduction
Acute inflammation is a critically important pathophysiological response to a local stimulus (e.g. bacterial infection) characterised by local tissue infiltration of neutrophils and tissue swelling (oedema).
These responses typically begin within minutes after a stimulus and collectively support the activation of essential immunoregulatory, pro-inflammatory and pro-resolution pathways required for effective host defence and tissue repair. Excessive and/or inappropriately triggered neutrophil migration and increased vascular leakage can also be the underlying cause of a vast range of acute and chronic inflammatory disorders, such as acute lung injury and rheumatoid arthritis, and are as such wellestablished anti-inflammatory therapeutic targets (1, 2) . Central to regulation of these responses are endothelial cells (ECs) that line the inner aspect of all blood vessels and provide the principal barrier to migrating immune cells and blood-borne macromolecules. With respect to neutrophil trafficking, ECs provide critical pro-adhesive and other effector molecules that facilitate a cascade of neutrophil-EC interactions, such as neutrophil rolling, firm arrest and luminal crawling, events that are generally considered to be pre-requisite to breaching of the endothelium (3) . Transendothelial cell migration (TEM) is supported by an array of EC junctional molecules, most notably PECAM-1 (CD31), members of the junctional adhesion molecule (JAM) family, VE-cadherin and others (3) (4) (5) . In addition, we recently demonstrated the importance of retaining directional cues within EC junctions in facilitating luminal-toabluminal neutrophil breaching of the endothelium (6) .
With respect to vascular leakage, under basal conditions the microvascular endothelium has a low permeability to plasma proteins, and as such establishes an oncotic gradient that opposes the vascular hydrostatic pressure that would otherwise excessively move water and solutes into the tissue. This situation rapidly changes in inflammation, enabling immediate supply of plasma proteins (e.g. complement components and antibodies) to injured or infected organs through increased permeability of the vascular endothelium (7) . Leakage of macromolecules in inflammation largely occurs via a paracellular route involving loosening of EC junctions (5, 7, 8) mediated via actinomyosin-based contraction of ECs and destabilisation of junctional contacts. The latter most notably involves downregulation of the adhesive functions of VE-cadherin (5, 8) with inflammation-induced increased vascular permeability being associated with elevated tyrosine phosphorylation of components of the VE-cadherin-catenin complex (5, 9) . Of particular significance, investigations using knock-in mice expressing specific point mutations in VE-cadherin tyrosine residues (i.e. VEC-Y685F and VEC-Y713F), have categorically identified distinct molecular mechanisms in governing the passage of neutrophils and macromolecules through EC junctions (9) . These findings are in line with early seminal works that definitively uncoupled in a temporal and spatial manner leukocyte extravasation from increased vascular permeability (10, 11) .
Despite this, the close association of stimulated neutrophil transmigration and vascular permeability has historically attracted much attention towards their potential interplay, and indeed, it is now generally accepted that neutrophils can promote microvascular leakage in the early stages of an acute inflammatory response (12, 13) . However, whether vascular permeability can regulate neutrophil migration remains poorly investigated and is contentious. To address this fundamental element of acute inflammation we used confocal intravital microscopy (IVM) to simultaneously analyse vascular leakage and neutrophil trafficking in inflamed tissues. Increased microvascular leakage did not influence the overall magnitude of neutrophil infiltration into tissues over several hours. Surprisingly however, leaky microvessels promoted a rapid and significant frequency of neutrophil reverse transendothelial cell migration (rTEM; ~20-40%) in the early phases of hyperpermeability reactions.
This aberrant behaviour was caused by an immediate increase in diffusion of interstitial chemokines into the vascular lumen, a response that disrupted the correct localisation of chemotactic cues within the venular wall niche. Furthermore, through development of an in vivo cell labelling method, we provide direct evidence for the ability of rTEM neutrophils that have stemmed from an inflammatory vascular leakage site to traffic to the lungs. Functionally, rTEM neutrophils were activated, and their presence within the pulmonary vasculature was aligned with sites of vascular injury, suggesting a pathological role for this sub-set of neutrophils. Collectively by identifying that local microvascular leakage induction facilitates movement of interstitial chemokines through EC junctions and entry into the vascular lumen, we have discovered an additional mechanism for promotion of neutrophil rTEM in vivo. Importantly, our findings directly link this cascade of events with the capacity of local hyperpermeability reactions to elicit remote organ damage.
RESULTS

Leaky venules support neutrophil reverse TEM
To directly investigate potential associations between neutrophil trafficking and microvascular permeability, inflamed mouse cremaster muscles were analysed for neutrophil breaching of EC junctions and microvascular leakage in real-time and in 3D (i.e. 4D) by confocal IVM. Briefly, the model employs LysM-EGFP-ki mice in conjunction with in vivo labelling of EC junctions using locally-applied non-blocking AlexaFluor-647 labelled (AF647) anti-CD31 mAb (14) . Neutrophil TEM was analysed through tracking of GFP bright neutrophils, and microvascular leakage was quantified by measuring interstitial accumulation of intravenously injected plasma protein tracer TRITC-dextran (MW ~75kDa) ( Figure 1A and Supplemental movie 1). In initial studies we analysed inflammatory responses induced by local injections of LTB4 and IL-1 and by a local pathophysiological insult of ischemia-reperfusion (IR) injury (all within 2-4h). Whilst these acute reactions elicited significant and comparable levels of total neutrophil infiltration into tissues within the overall test periods, as compared to control responses ( Figure 1B ), marked and rapid increased vascular leakage was only detected in tissues stimulated with LTB4 and IR ( Figure 1C ). Of note, overtime hyperpermeability reactions were associated with uptake of tissue infiltrated dextran by perivascular cells ( Figure 1A ) but these regions were excluded from the image analysis process.
Most importantly, in contrast to the normal neutrophil TEM observed in IL-1-stimulated tissues (i.e. neutrophils breaching EC junctions in a luminal-to-abluminal direction and without pause; Figure 1D and Supplemental movie S2), inflammatory reactions that increased vascular leakage were associated with the occurrence of neutrophil reverse TEM (rTEM) (Supplemental movie S3). Specifically, in LTB4and IR-stimulated tissues, and in line with our previous reports (14, 15) , a significant proportion of neutrophils that initiated TEM by extending protrusions through EC junctions rapidly retracted their cell body, exhibited reverse motility through EC junctions, and ultimately returned back into the blood circulation ( Figure 1D ). This mode of neutrophil TEM accounted for ~20-40% of all TEM events driven by LTB4 and IR but was rarely seen in IL-1-stimulated tissues (<5%) ( Figure 1E ). Using the IR reaction to analyse the onset of this phenomenon we noted that ~62% of the rTEM events occurred within the first 10min of the reperfusion phase ( Figure 1F ). In contrast, normal neutrophil TEM, as indicated via neutrophil accumulation in the perivascular tissue, was more sustained and continued to develop over the 2h reperfusion period analysed (data not shown). Of significance, whilst a close temporal association was observed between dextran leakage and frequency of neutrophil rTEM, the former exhibited an earlier onset (i.e. within less than 5min post reperfusion, Figure 1F ). This raised the possibility that increased EC permeability can influence the directionality of neutrophil TEM, prompting us to investigate the impact of vascular leakage enhancing stimuli, histamine and VEGF-A164 (VEGF) on rTEM.
In agreement with previously published reports (16, 17) , topical application of histamine to exteriorised cremaster muscles promoted neutrophil rolling but failed to induce neutrophil firm arrest or transmigration (Supplemental Figure 1A -C). Similarly, topical application of histamine to exteriorised IL-1-stimulated cremaster muscles caused no significant increase in neutrophil adhesion or transmigration beyond that seen with IL-1 alone (Supplemental Figure 1D and Figure 2A ). As anticipated, topical histamine induced a marked vascular leakage response in IL-1-treated tissues as compared to tissues treated with just IL-1 or PBS (Figures 2B, C and Supplemental movie S4), however, most intriguingly, it promoted a significant frequency of neutrophil rTEM events (~20%; Figure   2D and Supplemental movie 4). Similarly, whilst i.v. VEGF induced a notable vascular leakage response in mice treated with local IL-1 (Supplemental Figure 1E ) without impacting total neutrophil infiltration (Supplemental Figure 1F ), it caused a dramatic increase in frequency of neutrophil rTEM (~25%; Figure 2D ). Furthermore, in animals treated with IL-1+histamine, maximal neutrophil rTEM was again detected rapidly post topical application of histamine (~80% within 20min), in line with the rapid stimulated vascular leakage ( Figure 2E ). Collectively, the present findings demonstrate a previously unappreciated link between induction of vascular leakage and aberrant neutrophil TEM with the induction of leakage emphatically impacting the directional migration of neutrophils through EC junctions.
Genetic defect in microvascular leakage suppresses neutrophil reverse TEM
To further investigate the causal link between increased microvascular leakage and disrupted neutrophil TEM, we took advantage of a knock-in mouse model that expresses a Y685F mutant of VEcadherin (VEC-Y685F) and shows reduced vascular leakage but normal neutrophil extravasation (9) .
Knock-in mice expressing wild-type (WT) VE-cadherin (VEC-WT) were used as controls. To facilitate simultaneous quantification of neutrophil TEM dynamics and vascular leakage, chimeric mice were generated through adoptive transfer of bone-marrow from LysM-EGFP-ki donor mice into irradiated VEC-WT and VEC-Y685F recipients ( Figure 3A ). Using our model of local IL-1+histamine, VEC-Y685F chimeric mice showed reduced (~26%) interstitial dextran accumulation ( Figure 3B and C) with no significant change in total neutrophil extravasation over 2h ( Figure 3D ), as compared to responses detected in chimeric VEC-WT controls. These results are in line with the findings of Wessel and colleagues using the Miles assay in which 36% suppression of histamine-induced vascular leakage was detected in the dorsal skin of VEC-Y685F mice (9) . Of note, in agreement with our previous results ( Figure 2D ), IL-1+histamine caused a substantial frequency of neutrophil rTEM (~22%; Figure 3E ) in VEC-WT chimeric mice. However, mice harbouring the mutant form of VE-cadherin exhibited a significantly reduced frequency of this response (down to ~10%), culminating in ~55% inhibition of rTEM as compared to VEC-WT mice ( Figure 3E ). Together, our results provide compelling evidence for the ability of increased vascular leakage to disrupt luminal-to-abluminal motility of neutrophils through EC junctions resulting in neutrophil reverse TEM back into the vascular lumen.
Microvascular leakage promotes trafficking of interstitial chemokines into the blood stream
We next explored the mechanism through which vascular leakage induction promotes disrupted directionality of neutrophil TEM. Since our earlier works identified reduced EC junctional expression of JAM-C as a driver of incomplete and reverse modes of neutrophil TEM (14, 15) , this possibility was evaluated in the context of vascular leakage. However, local histamine, IL-1, or the combination of both mediators had no impact on expression of EC JAM-C (Supplemental Figure 2 ). In considering alternative mechanisms, we hypothesised that elevated microvascular permeability may alter the local chemotactic gradient across venular walls. To explore this notion, since IL-1 is an effective inducer of a potent neutrophil chemokine CXCL1 (18, 19) , we sought to investigate the impact of increased vascular leakage on generation and localisation of CXCL1 in IL-1-stimulated tissues.
IL-1-stimulation of WT cremaster muscles led to a robust increase in tissue and plasma CXCL1, as compared to PBS-treated mice ( Figure 4A -D). Whilst locally injected histamine or i.v. VEGF had no significant effect on IL-1-induced tissue levels of CXCL1, they elevated the associated plasma levels of CXCL1 ( Figure 4A -D). Of note, the vasoactive agents on their own did not induce either tissue or plasma CXCL1 ( Figure 4A -D). Similarly, as found with IL-1, TNF stimulation of cremaster muscles increased tissue and plasma CXCL1, with the latter being further elevated after local administration of histamine ( Figure 4A and B ). In addition, increased tissue and plasma CXCL1 were detected in mice subjected to the hyperpermeability-inducing reaction of cremasteric IR injury (Supplemental Figure 3 ).
These results imply that vascular permeability enhancing stimuli can promote the trafficking of endogenously generated CXCL1 from the tissue into the blood stream. To directly investigate this possibility, we asked a general but fundamental question: can an extravascular protein, comparable to the size of a chemokine (~8kDa), traffic into the blood stream through hyperpermeable leaky microvessels? To address this, we examined by confocal IVM the localisation of topically-applied small molecular weight (10kDa) AF488-dextran in control and histamine-treated IL-1-stimulated cremaster muscles. Here, vascular leakage was simultaneously quantified using i.v. injected high molecular weight (75kDa) TRITC-dextran. Superfusion of exteriorised cremaster muscles with 10kDa-AF488dextran (for 10min) led to its rapid and sustained accumulation in the extravascular space surrounding blood vessels ( Figure 4E and F and Supplemental movie 5). Topical application of histamine caused immediate leakage of blood-circulating 75kDa-TRITC-dextran into the interstitium ( Figure 4E and G and Supplemental movie 5), confirming induction of vascular leakage. Importantly, this effect was associated with rapid (<5min) disappearance of the 10kDa-AF488-dextran signal from the perivascular space, as compared to tissues treated with topical vehicle ( Figure 4E , F and G). Furthermore, in mice treated with topical histamine, a significant level of 10kDa-AF488-dextran was detected in plasma ( Figure 4H ).
Collectively these results demonstrate that under conditions of enhanced vascular permeability, a small MW protein can diffuse from the interstitium into the blood stream against an advective flow in the opposite direction. As seemingly unexpected, further validation of these experimental findings were sought through mathematical modelling. Briefly, as the molecular flux across the vessel wall is determined by a combination of diffusive and advective transport, for a small MW protein in the extravascular compartment (e.g. 10kDa dextran or a chemokine) to enter the blood circulation, the diffusive flux from tissue to blood must be high enough to overcome the opposing advective flux ( Figure   4I ). This ratio is defined by the Péclet number (Pe) ( Figure 4I ). If the Pe is substantively less than 1, then there can be diffusion against an advective flow of fluid. If the Pe is >1 then diffusion cannot effectively oppose filtration -in other words for a molecule to diffuse against a flow of fluid Pe needs to be <1. Using previously published values for the hydraulic conductivity properties of ECs, and known diffusion coefficients, the Pe number for a 10kDa dextran in cremaster muscle microvessels is calculated to be ~0.8 under normal conditions (Supplemental Figure 4 ). Such a scenario would allow some diffusion of interstitial protein into the vascular lumen, in line with our experimental data ( Figure   4H ). However, under conditions of increased vascular permeability (e.g. as induced by local histamine) this falls substantially to values at which diffusion dominates advective flux (i.e. Pe<0.3; Figure 4I and Supplemental Figure 4 ). This modelling of the molecular flux across cremasteric venular walls supports our experimental data and provides additional endorsement for the concept that vascular hyperpermeability can facilitate the trafficking of extravascular small molecules into the vascular lumen.
We next directly assessed the capacity of an interstitial chemokine to engage with EC junctions and to leak from the tissue into the bloodstream post vascular permeability induction. For this purpose, we analysed the localisation of human CXCL8 (hCXCL8) in relation to ECs, when locally applied to IL-1stimulated cremaster muscles, in the presence or absence of histamine. Although in control tissues the chemokine was modestly aligned with the endothelium, this was significantly elevated post local application of histamine, most notably in relation to EC junctions ( Figure 5A and B ). Furthermore, whilst locally injected hCXCL8 could be detected in plasma of mice treated with IL-1only, this response was significantly increased (~42%) in mice treated with IL-1+histamine ( Figure 5C ). A similar increase in plasma levels of locally injected hCXCL8 was noted in mice treated with IL-1+VEGF as compared to animals treated with IL-1+vehicle (Supplemental Figure 5 ). Furthermore, VEC-Y685F mutant mice that exhibit a defect in vascular permeability induction (9) ( Figure 3B and C), showed reduced plasma levels of hCXCL8 as compared to levels detected in control VEC-WT animals ( Figure 5D ). The link between vascular permeability induction and tissue to blood chemokine movement was further investigated through the use of blocking anti-VE-PTP and anti-VE-cadherin antibodies. Specifically, an anti-VE-PTP Ab that inhibits vascular permeability induction through activation of Tie-2 (20, 21), (i) significantly suppressed histamine-induced vascular leakage in the mouse cremaster muscle (Supplemental Figure 6A) , and, (ii) significantly reduced plasma levels of locally administered hCXCL8 in mice treated with IL-1+histamine, as compared to control Ab treated-mice ( Figure 5E ). Animals treated with the anti-VE-PTP Ab also showed reduced plasma levels of endogenously generated CXCL1 as compared to levels detected in control Ab-treated mice (Supplemental Figure 6B) . In contrast to the inhibitory effects of the anti-VE-PTP Ab, a blocking anti-VE-cadherin mAb (clone BV13) (22) that promoted vascular leakage induction in the mouse cremaster muscle (Supplemental Figure   6C and D), enhanced plasma levels of locally administered hCXCL8 as compared to levels detected in control mAb (anti-CD31)-treated mice ( Figure 5F ).
Together, through experimental and mathematical modelling, we provide compelling evidence to show that the loosening of EC junctions during increased vascular permeability can promote the mobilisation of small MW proteins from the interstitial tissue to the blood stream and thus influence the compartmentalisation of extravascular chemokines.
Luminal CXCL1 promotes neutrophil reverse TEM
We next investigated the functional impact of increased plasma CXCL1 on neutrophil TEM. For this purpose, 2h post stimulation of cremaster muscles with IL-1, LysM-EGFP-ki mice were injected i.v. with a blocking anti-CXCL1 mAb prior to topical application of histamine. Whilst at the dose employed, i.v. administration of the anti-CXCL1 mAb had no impact on plasma protein leakage or total neutrophil extravasation ( Figure 6A and B), this intervention significantly reduced the frequency of neutrophil rTEM events (~60% inhibition) as compared to control Ab-injected mice ( Figure 6C ). Similarly, systemic CXCL1 blockade had no impact on total neutrophil extravasation in cremaster muscles subjected to IR insult ( Figure 6D ) but suppressed neutrophil rTEM in this permeability-enhancing reaction (~60% inhibition; Figure 6E ). Suggesting that luminal CXCL1 can drive neutrophil rTEM, this was categorically investigated through i.v. injection of exogenous CXCL1 in LysM-EGFP-ki mice stimulated locally with IL-1 (2h). Within this protocol, i.v. CXCL1 promoted a substantial frequency of neutrophil rTEM through cremasteric venules (~30%; Figure 6F ), whereas as noted previously ( Figure 1E ), local IL-1 on its own did not cause neutrophil rTEM ( Figure 6F ). Collectively, the present results unequivocally demonstrate that vascular CXCL1 can drive neutrophil TEM towards the luminal aspect of the endothelium.
Development of a cell labelling strategy for tracking of neutrophil rTEM in vivo
Aiming to gain insight into the fate, phenotype and pathophysiological relevance of rTEM neutrophils stemming from a local hyperpermeability inflammatory site, we established a method for tracking of these cells. Previous studies employing zebrafish and murine models of tissue injury have utilised genetically encoded photolabelling protocols to track reverse migrating neutrophils from within injured interstitial tissues back into the vascular lumen and into distal organs (23) (24) (25) . However, as the neutrophil reverse migration phenomenon noted in the present study is restricted to breaching of the endothelium only, photoconverting and photoactivation of neutrophils confined within tight EC junctions or the thin sub-EC space (<3m wide) renders such genetic strategies inappropriate for exclusive delineation of rTEM cells (e.g. preliminary works with transgenic mice expressing the Kaede photoconvertible fluorescence protein tracked <10 rTEM neutrophils/inflamed tissue; data not shown).
Hence, as part of the present study we have developed a labelling method that crisply delineates neutrophils that reverse migrate within EC junctions and re-enter the vascular lumen ( Figure 7A ). The method takes advantage of the strong affinity of streptavidin for biotin and our observation that locally applied streptavidin is retained within the cremaster muscle tissue and does not move into the systemic circulation, even under conditions of increased vascular permeability (Supplemental Figure 7A ). Initial experiments applied this labelling method to staining of neutrophils in IL-1-stimulated tissues. Briefly, after local application of IL-1 (1.5h), LysM-EGFP-ki mice were injected i.v. with biotinylated anti-Ly6G mAb, a step that as anticipated selectively labelled >99% of all circulating neutrophils (Supplemental Figure 7B ). Thirty minutes later, cremaster muscles were surgically exteriorised and tissues were topically superfused with AF647-streptavidin. Analysis of tissues by confocal microscopy showed that with this protocol luminal neutrophils were GFP + but streptavidin -, whilst neutrophils in the sub-EC space and in the interstitial tissue were clearly positive for both GFP and streptavidin ( Figure 7B ). We next sought to investigate the ability of this labelling method to track rTEM neutrophils during the hyperpermeability IL-1+histamine reaction where histamine and AF647-streptavidin were simultaneously superfused onto surgically exteriorised tissues. Here, intriguingly we noted that in neutrophils exhibiting TEM, leading protrusions in the sub-EC space rapidly became intensely streptavidin + ( Figure 7C ), resulting in effective labelling of all neutrophils that partially or fully breached the endothelium. This included cells that completely breached the venular wall and entered the surrounding interstitial tissue as well as cells that reverse migrated from within EC junctions or the sub-EC space back into the vascular lumen ( Figure 7A 
Reverse TEM neutrophils disseminate into the systemic and pulmonary circulation and exhibit an activated phenotype
Exploiting our labelling method, we next investigated the distribution of rTEM neutrophils stemming from local hyperpermeability sites. Since our confocal IVM studies showed rTEM neutrophils to reenter the vascular lumen and rapidly detach from the luminal aspect of the endothelium (Supplemental Video 6), we initially sought to detect these cells in the systemic circulation. For this purpose, using mice subjected to cremasteric stimulation with IL-1, blood samples were taken two hours post local administration of histamine or vehicle in conjunction with the new biotin-streptavidin labelling protocol.
Flow cytometry analysis of samples from IL-1-treated mice showed very low levels of streptavidin + circulating blood neutrophils (~0.1%, corresponding to a total of ~800 streptavidin + neutrophils/ml of blood); this number was significantly increased in blood samples of mice locally stimulated with IL-1+histamine (~0.4%, corresponding to ~2,800 streptavidin + neutrophils/ml of blood) ( Figure 8A and B). Aligned with the substantive frequency of neutrophil rTEM seen in the corresponding reactions (see Figure 2D ), these results strongly indicated the presence of rTEM neutrophils in the systemic circulation. Focussing on the hyperpermeability reaction to IL-1+histamine, we next explored the phenotype of streptavidin + neutrophils as compared to streptavidincells. Streptavidin + blood neutrophils exhibited no significant change in expressions of L-selectin (CD62L), 1 integrins, ICAM-2, neutrophil elastase (NE) or CXCR4 but showed significantly increased expression of CD11b, and a low but significant increase in expression of ICAM-1 (Supplemental Figure 9A and Figure 8C ). Based on such an activated phenotype, and as guided by our previous works (14, 15) , we hypothesised that streptavidin + rTEM neutrophils may be additionally retained within the pulmonary vasculature. To address this possibility, we analysed the percentage and phenotype of streptavidin + neutrophils in pulmonary vasculature washouts of mice subjected to local cremaster muscle stimulations with PBS, histamine, IL-1 or IL-1+histamine (2h) and biotin-streptavidin labelling. Whilst animals treated locally with PBS, histamine or IL-1 showed similar levels of streptavidin + neutrophils (~0.2%), mice stimulated with IL-1followed by histamine for 2h showed an enrichment of streptavidin + neutrophils in the pulmonary vasculature (~0.8%) ( Figure 8D and E). Increasing the local stimulation period with histamine to 4h resulted in a similar level of streptavidin + neutrophils in blood (~0.42%) but led to a reduced and non-significant level in the pulmonary vasculature (~0.2%) (Supplemental Figure 9B and C). Interestingly, in mice treated locally with IL-1 followed by 4h stimulation with histamine, but not 2h, a significant level of streptavidin + neutrophils was detected in the bone marrow (Supplemental Figure  9D , E, F and G). Together these results suggest that the retaining of rTEM neutrophils in the lungs is transient and that this subset of cells eventually migrate to the bone marrow. Furthermore, as compared to streptavidincells, streptavidin + pulmonary vascular neutrophils showed no significant change in expressions of L-selectin and ICAM-2 but exhibited a significant increase in expressions of 1 integrins, CD11b, ICAM-1, NE and CXCR4 ( Figure 8F and G). The latter is in line with the observed trafficking of the streptavidin + cells to the bone marrow. Of note, in IL-1+histamine-treated mice subjected to our labelling protocol, streptavidinneutrophils in both blood and pulmonary vascular washout samples showed a similar phenotype to neutrophils acquired from un-labelled mice treated locally with just PBS, histamine or IL-1 alone (Supplemental Figure 10A and B). This crucial set of data precludes the possibility that in IL-1+histamine-treated mice circulating soluble factors determine the phenotype of the streptavidin + cells. Additionally, these results suggest that the streptavidin + rTEM neutrophils have no impact on the phenotype of streptavidinneutrophils.
Together, we provide evidence for the ability of rTEM neutrophils stemming from a local hyperpermeability site to re-enter the systemic circulation and to traffic to lungs, where they exhibit an activated pro-adhesive phenotype, before returning to the bone marrow.
Disseminated rTEM neutrophils localise to sites of vascular leakage in lungs
We have previously shown an association between rTEM neutrophils stemming from local inflammatory sites characterised by reduced junctional expression of EC JAM-C and remote organ injury (14, 15) . We therefore hypothesised that neutrophil rTEM driven by local hyperpermeability could similarly cause distant organ damage. To investigate this notion, pulmonary vascular leakage resulting from stimulation of cremaster muscles was assessed by measuring sub-EC and extravascular accumulation of intravenously administered fluorescent microspheres (26) . Furthermore, to investigate if this response was associated with accumulation of rTEM neutrophils stemming from the cremaster muscle, the experiments incorporated the new biotin-streptavidin labelling protocol. Our findings showed that mice subjected to cremaster muscle stimulation with IL-1histamine, but neither stimulus reactions tested exhibited similar levels of total neutrophil recruitment to lungs (~15 neutrophils/field of view), a significantly elevated number of streptavidin + neutrophils was detected in lungs of mice subjected to cremaster muscle local hyperpermeability ( Figure 9C ). Furthermore, these studies indicated a significant association between numbers of streptavidin + neutrophils and the extent of increased lung vascular permeability ( Figure 9D ) and a significant association between the presence of streptavidin + neutrophils and sites of pulmonary vascular leakage ( Figure 9E and F) . Collectively, the findings demonstrate that a local hyperpermeability reaction can promote distal organ injury by recruitment of rTEM neutrophils ( Figure 10 ).
DISCUSSION
Enhanced microvascular leakage and neutrophil trafficking are pivotal features of an acute inflammatory response. Importantly, the molecular basis of these events are distinct (9) and there is ample evidence to show that neutrophil extravasation in vivo per se is not sufficient for increased microvascular leakage (present study and (10, 11) ). None-the-less, neutrophils, most notably when stimulated to adhere by certain chemoattractant mediators (27, 28) , can secrete a range of propermeability factors (e.g. VEGF, LTA4, HBP, TNF) (12, 13, (29) (30) (31) . Here we report for the first time that Intrigued by the lack of investigations into the potential impact of increased vascular permeability on neutrophil trafficking, we applied high resolution confocal IVM for simultaneous analysis of these phenomena. Our findings revealed that induction of vascular leakage does not grossly alter total tissue infiltration of neutrophils over several hours. However, unexpectedly, augmented vascular leakage rapidly promotes a significant frequency of neutrophils that have initiated TEM to exhibit retrograde motility within EC junctions and eventually re-enter the blood circulation. Increased microvascular permeability consistently preceded the occurrence of this aberrant TEM response, suggesting a causal link. Direct evidence for this notion was acquired through the use of knock-in mice expressing a Y685F mutant of VE-cadherin with selective impaired vascular permeability induction (9) that showed reduced disrupted neutrophil TEM. Neutrophil reverse migration within EC junctions, termed "reverse TEM", has previously been described by our group in relation to multiple inflammatory scenarios in the murine microcirculation (6, 14, 15) . This response, which was first described in vitro for human neutrophils (32) is, however, one of a number of neutrophil reverse migration modes that to date have been reported in numerous contexts, experimental models and inflammatory conditions (23) (24) (25) (33) (34) (35) . The wideranging profiles and potential implications of neutrophil retrograde migration begs the need for further explorations of this enigmatic response in terms of its mechanisms and consequences.
In addressing the mechanisms that drive neutrophil rTEM, our previous works identified neutrophil elastase-mediated cleavage of EC junctional JAM-C as a trigger of this cellular response (14, 15) .
Together with in vitro studies of monocyte TEM (36), these findings indicated a need for EC JAM-C as a regulator of one-way leukocyte trafficking through EC junctions, though the precise molecular basis of JAM-C-mediated luminal-to-abluminal neutrophil motility remains unclear. Of note however, directlyacting vascular permeability enhancing agents (histamine and VEGF) that effectively instigated neutrophil rTEM in IL-1-stimulated tissues, had no impact on JAM-C expression. As an alternative mechanism, and based on recent findings showing the significance of compartmentalised directional cues in promoting neutrophil diapedesis (6), we hypothesised that increased vascular permeability may disrupt the correct positioning of chemotactic signals within the venular wall niche. Focussing on CXCL1, a potent neutrophil chemoattractant abundantly generated within our acute inflammatory models, elevated plasma levels of this chemokine were noted in all hyperpermeability reactions tested.
Intriguingly, these results suggested that vascular leakage can prompt the diffusion of endogenously generated CXCL1 from the tissue and/or the venular wall into the vascular lumen. Support for this notion was acquired through tracking of topically applied 10kDa dextran in histamine-stimulated tissues by confocal IVM and such an event was predicted by mathematical modelling. Briefly, whilst under normal homeostatic conditions, intact EC contacts provide a significant barrier to movement of molecules into tissues, this situation changes in inflammation. When vascular permeability is increased, EC junctional contacts loosen and although this supports increased hydraulic flux, it also causes a decrease in hydraulic velocity. Such a scenario can facilitate diffusion of a small molecule (e.g. a chemokine) from the tissue back into the blood stream as shown here both experimentally and mathematically. This hypothesis was conclusively validated through assessing the interstitial to vascular lumen distribution of exogenous hCXCL8 following specific genetic or pharmacological modulations of vascular permeability induction. Collectively, the findings reveal that hyperpermeability inflammatory conditions can promote reverse diffusion of chemokines from the tissue to the vascular lumen, a phenomenon that can disrupt the directional motility of neutrophils through EC junctions. The latter was definitively illustrated in experiments where systemic blockade of CXCL1 prevented neutrophil rTEM in hyperpermeability reactions, and conversely, intravenous exogenous CXCL1 promoted neutrophil rTEM.
The sequence of molecular and cellular events that guide neutrophils from the vascular lumen to the interstitial tissue is well established and described by the leukocyte adhesion cascade (3). Here, it is considered that chemokines immobilised on the luminal aspect of blood vessels trigger the local arrest of neutrophils (3) with sequential, compartmentalised and locally presented chemotactic cues within venular walls promoting luminal-to-abluminal diapedesis (6) . Whilst glycosaminoglycans (GAGs) are considered to provide the principal mode of retaining chemokines on the luminal aspect of blood vessels, the retention of chemokines within EC junctions is likely mediated by binding to the atypical chemokine receptor ACKR1 that is enriched at these sites (6, 37) . Together, due to their pivotal role in localisation, retention and/or transport of chemokines, ACKR1 and GAGs are key molecular players in supporting leukocyte trafficking (38, 39) . In contrast to these physiological regulatory modes, increased vascular permeability appears to account for excessive EC junctional motility and resultant entry of chemokines into the blood stream. As such, local hyperpermeability disrupts the correct spatiotemporal presentation of chemotactic cues within venular walls, and in doing so, disrupts a phenomenon that is critical for efficient and unidirectional luminal-to-abluminal migration of neutrophils (6) .
Although migration away from sites of inflammation and injury is now an established neutrophil behaviour (34) , it is highly plausible that the implications of this response are different in diverse contexts and in varied experimental models. Most notably, neutrophil retrograde motility within interstitial tissues away from sites of sterile injury, and in some cases re-entry into the blood circulation, is proposed as a component of inflammation resolution (24, 33, 40, 41) . For example, Wang and colleagues reported that neutrophils recruited to a murine thermal hepatic injury model contributed to revascularisation of injured tissues and subsequently left the injured site by re-entering the local vasculature (24) . Using an elegant mouse model that selectively expressed a photoactivatable GFP in neutrophils, the authors could track ~10% of the tissue infiltrated neutrophils, a procedure that enabled a small number of cells to be tracked to the lungs and a higher number to the bone marrow. Phenotypic analysis of photoactivated neutrophils in these organs indicated increased expression of CXCR4.
Based on the latter, it was concluded that neutrophil migration away from injured tissues is a physiological process that may regulate deactivation and/or reprogramming of neutrophils in the lungs before they are recruited to the bone marrow via CXCR4 for eventual clearance by apoptosis (24) . The neutrophil reverse motility response reported in our study is distinctly different from that analysed by Wang and colleagues in that it is restricted to EC junctions and the sub-EC space and collectively describes the re-entry of transmigrating neutrophils back into the vascular compartment prior to the cells fully exiting the venular wall. Whilst we have previously associated this response with remote organ damage (14, 15) , our earlier works did not provide direct evidence for rTEM neutrophils trafficking to secondary organs. To address this vital point, here we have developed an in vivo cell-labelling method that precisely and efficiently distinguishes luminal neutrophils from all cells that breach EC junctions and hence tags all TEM and rTEM neutrophils stemming from the tissue under investigation.
As such, a notable strength of our method is that it enables analysis of the full sub-population of rTEM neutrophils migrating away from an inflammatory site in terms of their fate, phenotype and pathophysiological relevance.
The application of our tracking method indicated dissemination of labelled rTEM neutrophils from a local hyperpermeability site to the systemic circulation where they showed an activated phenotype (increased CD11b and ICAM-1). In the same animals, labelled rTEM neutrophils were detected at significantly elevated levels in the pulmonary vasculature with an even greater activation state, exhibiting further increased expressions of CD11b and ICAM-1, as well as 1 integrins and NE. The latter is highly indicative of degranulation contributing to some of the noted rTEM neutrophil phenotype and indeed neutrophils are known to express preformed stores of 2 and 1 integrins that can be mobilised to the cell surface during TEM (42) . Certainly, there is ample evidence showing that engagement of neutrophils with EC junctional molecules can trigger signalling and transcriptional events within migrating leukocytes (42) , suggesting that rTEM and tissue infiltrated neutrophils may exhibit similar phenotypes. In line with this notion, whilst increased expression of ICAM-1 on neutrophils is a slow and transcriptionally regulated process (43) , both tissue infiltrated and rTEM neutrophils can exhibit an ICAM-1 hi phenotype (14, 32, 43) . Of importance however, although increased expressions of integrins, other granular proteins and ICAM-1 on tissue infiltrated neutrophils collectively support effective breaching of venular walls, interstitial tissue migration and pathogen clearance (42) (43) (44) (45) (46) , such a phenotype on neutrophils that re-enter the blood circulation could be highly detrimental to the host.
In line with this notion, we detected a direct association between labelled rTEM neutrophils and lung injury, results that support the paradigm that rTEM neutrophils are a sub-set of activated neutrophils that can contribute to turning a local inflammatory response into a systemic phenomenon. The precise mechanism through which rTEM neutrophils exert tissue damage remains to be elucidated. However, the strong association of NE with the pathogenesis of numerous acute and chronic lung disorders (47) suggest increased expression of this serine protease on rTEM neutrophils could be a significant factor. Furthermore, elevated expression of integrins, together with the ICAM-1 hi phenotype, may support increased aggregation and activation of rTEM neutrophils (e.g. degranulation and ROS generation) within small blood vessels of remote organs. Of direct relevance to this notion, we have previously shown that neutrophil ICAM-1 expression correlates with increased ROS generation (43) . Additionally, pulmonary vasculature (but not blood) rTEM neutrophils showed increased expression of CXCR4, and rTEM neutrophils could be detected in the bone marrow four hours post their induction. These results collectively support the belief that neutrophils are retained within the lung vasculature in a transient manner during which they may be reprogrammed for homing to the bone marrow (24) . The difference between our findings and those of other groups in terms of linking neutrophil rTEM to distant organ damage could lie in the nature of the reactions investigated, the type of retrograde migration being analysed and phenotype of the neutrophils stemming from the primary inflammatory site. Significant to our findings, acute lung injury is a life-threatening consequence of numerous local hyperpermeabilityinducing conditions such as trauma, and pathologies induced by IR injury (48, 49) . Thus, we propose that activated rTEM neutrophils stemming from local hyperpermeability inflammatory sites could provide a detrimental "cellular" link between primary and secondary sites of pathological inflammation.
In summary, the present results offer a causal link between increased local microvascular leakage and neutrophil rTEM, an axis associated with development of remote organ damage. Fundamental to this cascade of events is the discovery that increased vascular leakage can induce rapid translocation of chemokines from the interstitium into the systemic circulation against hydraulic flow, resulting in disrupted directional gradient across the venular wall. This response in turn drives the re-entry of an activated sub-set of neutrophils back into the vascular lumen that can then contribute to development of lung injury. Collectively, our findings suggest that targeting excessive local microvascular permeability maybe a plausible therapeutic strategy for protecting the host from secondary organ damage. Furthermore, our results could have implications for tumour cell intravasation and dissemination from primary sites of tumour growth that are characterised by leakiness of their blood vessels.
METHODS
Antibodies
The following were obtained commercially: Anti-CD31 (390) 
Animals
Male WT C57BL/6 (Charles River, UK) and LysM-EGFP-ki (51) mice (8-12 weeks old) were used for all studies. VEC-Y685F-ki mutant mice that exhibit a single point mutation in VE-Cadherin were generated as previously described (9) .
Generation of chimeric mice
VEC-WT and VEC-Y685F mice were lethally irradiated with 1 dose of 9 Gy over a time period of 11min and were subsequently injected i.v. with 1.5-3x10 6 bone marrow cells from LysM-EGFP-ki mice. Level of engraftment was evaluated 4 weeks after reconstitution and all mice showed more >99% of GFP + neutrophils with similar neutrophil counts.
Confocal IVM of the mouse cremaster muscle
Anaesthetised (isofluorane, 3%) male mice received an intrascrotal (i.s.) injection of fluorescentlylabelled anti-CD31 mAb (4g) and/or IL-1 (50ng, R&D Systems, UK), LTB4 (300ng, Cambridge Bioscience, UK) to label vessels within the tissue and/or induce an inflammatory response, respectively. Control animals received PBS. The cremaster muscles were then prepared for intravital imaging 2h or 30min post IL-1 or LTB4 administrations, respectively, as described (14, 15) . Topical application of histamine (30M, Sigma-Aldrich) onto exteriorised tissues, or intravenous (i.v.) injection of VEGF (4g/mouse, R&D Systems) was used to induce vascular leakage. Ischemia-reperfusion (IR) injury was induced as described (14, 15) . In some experiments, anti-CXCL1 mAb or control IgG2a was injected i.v. 1.5h after IL-1 stimulation of tissues. Following exteriorisation, the cremaster muscle was superfused with AF647-streptavidin (1g/ml, ThermoFisher) with Tyrode's solution with or without histamine (30M). Z-stack images of post-capillary venules (20-40m in diameter) were captured using Leica SP5 or SP8 confocal microscopes incorporating a x20 water-dipping objective (NA 1.0), as detailed (6, 14) .
Quantification of neutrophil TEM, microvascular leakage and streptavidin labelling
Still images and 4D live recordings were analysed using IMARIS software™ (Bitplane, Zurich, Switzerland). Extravascular neutrophils were defined as those that had fully transmigrated and passed through the pericyte layer, recognisable via a change in their morphology and expressed as number of cells/mm 3 of tissue. Reverse TEM neutrophils were defined as cells that moved in an abluminal-toluminal direction within EC junctions. Normal neutrophil TEM was classified as a response in which the cells migrated through EC junctions only in a luminal-to-abluminal direction, as previously described (14, 15) . Extravascular leakage was quantified by interstitial accumulation of i.v. 75kDa-TRITC-dextran and presented as MFI of indicated time-points, measuring 6-8 regions of interest (ROI) in the interstitium (excluding areas exhibiting dextran-positive perivascular cells) and 30m away from the vessel wall. These readings were then normalised in relation to the first two MFI readings obtained post i.v. injection of the tracer and presented as normalised MFI. Similar analysis was conducted for the quantification of tissue levels of 10kDa-AF488-dextran (MFI normalised to the first two readings post superfusion of the tracer). Interstitial neutrophil speed and fluorescence intensity of AF647streptavidin were analysed using the spot or iso-surface functions of IMARIS software, respectively.
Bright-field IVM of the mouse cremaster muscle
Mice were injected i.s. with IL-150ng) or PBS alone for 2h prior to cremaster muscle exteriorisation and prior to the superfusion of histamine (30M) or vehicle, as described above. Leukocyte rolling, firm arrest and extravasation within 20-40m post-capillary venules were quantified by IVM over a 1.5h period using a bright-light microscope (Axioskop FS, Carl Zeiss, UK), as detailed (44) . Several vessel segments (3-5) from multiple vessels (3) (4) (5) were quantified for each animal.
Quantification of chemokine and dextran levels in tissue and plasma
Anaesthetised (isofluorane 3%) mice were subjected to cremasteric ischemia (40min) or injected i.s. were harvested 30min later. In some experiments hCXCL8 (500ng, Peprotech) was co-injected with IL-1 (50ng) for 1h prior to the end of the in vivo test period (i.e. 2.5h). In some experiments, mice were treated i.v. with a blocking anti-VE-PTP Ab (200g) (20, 21) or rabbit IgG control (200g) 30min after hCXCL8 and IL-1 injection. Other experiments involved treating the mice with a blocking anti-VE-cadherin mAb (BV13; 100g) (22) or a control mAb (anti-CD31 mAb, clone 390; 100g) i.s. for 3h followed by local injection of hCXCL8 for 1h prior to tissue and plasma collection. Tissues were homogenised in PBS containing 0.1% Triton X-100 and 1% Halt Protease and Phosphatase Inhibitor cocktail (ThermoFisher) and mechanically dissociated using the Precellys24 beat-beading system (Bertin Technologies, France). Levels of mCXCL1 and hCXCL8 were analysed as per the manufacturer's instructions by ELISA (R&D Systems and ThermoFisher, respectively, sensitivity: 2pg/ml). The quantity of chemokine detected in tissues was normalised to protein content as determined using a BCA assay (Thermo Fisher). Levels of 10kDa-AF488-dextran in plasma was quantified using a NOVOstar (0700) microplate reader.
Immunofluorescence staining and confocal analysis of tissues
Whole-mount cremaster muscles were analysed for expressions of hCXCL8, JAM-C, red-(580/605)microbeads (20nm in diameter, 9.1x10 13 beads; ThermoFisher Waltham, MA, USA), and AF647streptavidin as previously published (6, 15) . Briefly, surgically removed tissues were fixed in ice-cold PFA (4% in PBS) for 45min, blocked and permeabilised at room temperature for 4h in PBS containing 25% FCS and 0.5% Triton X-100, and incubated overnight (anti-hCXCL8, anti-MRP14, anti--SMA, anti-CD31 staining) or 72h (anti-JAM-C staining) at 4°C with primary antibodies. Immunostained tissues were imaged with an inverted Zeiss 800 confocal laser-scanning microscope. JAM-C expression within the VE-cadherin channel was quantified as previously described (14, 15) . For analysis of hCXCL8 localisation, ECs, neutrophils and pericyte isosurfaces were created based on regions immunostained for CD31 (CD31 high junctional and CD31 dim non-junctional regions), MRP14
and -SMA, respectively. EC body and junctional hCXCL8 expressions were quantified as MFI within these isosurfaced regions. The MFI of fluorescent beads present in the sub-endothelial space (<1m from ECs) was quantified as a measure of cremaster muscle vascular leakage. An isosurface using the CD31 channel was generated to exclude fluorescent signal of beads inside the vascular lumen. All protein expression levels were quantified from 6-12 images/tissue and expressed as MFI values of tissues stained with specific antibodies post subtraction of MFI values acquired from tissues stained with isotype control antibodies.
Analysis of blood, pulmonary vascular washout and bone marrow neutrophils by flow cytometry
Mice received an i.v injection of biotin-anti-Ly6G mAb (2g) 90min post stimulation of cremaster muscles with locally administered IL-1(50ng) or PBS. Mice were locally injected 30min later with histamine (200l of 30M solution) or PBS in combination with AF647-streptavidin (400ng). Whole blood and lung vascular washout were collected 120-240min later as previously described (14, 15) , a method that recovered ~50% of the lung pulmonary vascular neutrophils. Bone marrow was isolated from 1 femur/animal. The samples were then analysed using an LSR Fortessa flow cytometer (Becton Dickinson) and FlowJo software (TreeStar). Following doublets exclusion, neutrophils from LysM-EGFP-ki and WT mice were gated as LysM-EGFP high /GR-1 high or GR-1 high /CD115 -, respectively.
Leukocyte numbers were determined using fluorescent counting beads.
Analysis of lung vascular leakage
Pulmonary vascular leakage was quantified by adapting published methods (26) . Briefly, mice were Zeiss 800 confocal laser scanning microscope. The MFI of fluorescent beads present in the extravascular space (from 5-7 images/tissue from different lung lobes) was quantified as a measure of lung vascular leakage. For this purpose, an isosurface was generated using the anti-CD31 mAb to exclude fluorescent signal of beads inside the vascular lumen. To quantitatively analyse the association between strept + neutrophils and regions of vascular leakage, we arbitrarily defined strept + neutrophil regions as areas that expressed at least one strept + neutrophil within a perimeter of 60m. Control areas within the same image were defined as similar size regions that were devoid of strept + neutrophils.
Statistical analysis
Data analysis was performed using GraphPad Prism 6 (GraphPad software). Results are expressed as mean±SEM and the n numbers for each dataset is provided in the figure legends. Statistical significance was assessed by 2 tailed Student's t test, one-way or two-way ANOVA followed by Bonferroni's post-hoc test. A P value less than 0.05 was considered significant.
Study approval
All in vivo experiments were conducted under the UK legislation according to the Animal Scientific Procedures Act 1986, with all procedures being conducted in accordance with UK Home Office regulations. Figure 4 ). Data are represented as mean±SEM (each dot represents one mouse/independent experiment). Statistically significant differences from PBS (A-D) or IL1+vehicle (H) are indicated by *p<0.05,**p<0.01,***p<0.001, between groups as indicated by lines by #p<0.05, one-way ANOVA followed by Bonferroni's post-hoc test or two-tailed Student's t-test (ns = not significant). BV13, 100g ), or a control mAb (non-blocking anti-CD31 mAb, 100g) for 3h prior to local administration of tissues with hCXCL8 for 1h (n=4-8 mice/group) (F). Data are represented as mean±SEM (each dot represents one mouse/independent experiment). Statistically significant differences cell body vehicle vs cell body histamine and Jn vehicle vs Jn histamine groups were analysed by one-way ANOVA followed by Bonferroni's post-hoc test (*p<0.05,**p<0.01). Differences between the other indicated groups are shown by *p<0.05,**p<0.01,***p<0.001 analysed by two-way ANOVA followed by Bonferroni's posthoc test or two-tailed paired or unpaired Student's t-test. Figure 6 . Systemic CXCL1 promotes neutrophil reverse TEM. Cremaster muscles of LysM-EGFPki mice were stimulated with IL-1 (50ng for 2h) followed by topical superfusion of histamine onto exteriorised tissues or subjected to IR injury. Blocking anti-CXCL1 mAb (1mg/kg), or control IgG, was injected i.v. 30min before exteriorisation of tissues or at the point of tissue reperfusion. (A) Time-course of dextran accumulation in the perivascular region of selected stimulated post-capillary venules. Tissue dextran accumulation is represented as normalised MFI (n=4-6 mice per group). (B) Total neutrophil extravasation (n=4-5 mice/group) and (C) frequency of neutrophil reverse TEM events in relation to total TEM events of 14±2 (control mAb) and 20±2.9 (anti-CXCL1 mAb) per 300m venular segments within 2h microscopy periods (mean ± SEM, (n=5-6 mice/group). (D) Total neutrophil extravasation (n=3-6 mice/group) and (E) frequency of neutrophil reverse TEM events in relation to total TEM events of 26.7±3.8 (control mAb) and 26±4.3 (anti-CXCL1) per 300m venular segments within 2h microscopy periods (mean ± SEM, n=3-7 mice/group). (F) Cremaster muscles of LysM-EGFP-ki mice were stimulated with IL-1 (50ng for 2h) followed by i.v. injection of murine rCXCL1 (50ng). Frequency of neutrophil reverse TEM events in relation to total TEM events of 16±2.8 (IL-1) and 12.9±1.8 (IL-1+CXCL1) per 300m venular segments within 2h microscopy periods (mean±SEM, n=5-7 mice/group). Data are represented as mean±SEM (each dot represents one mouse/independent experiment). Statistically significant differences from control mAb-treated groups (C and E) or IL-1 treated-tissues (F) are shown by *p<0.05,***p<0.001, two-tailed Student's t-test. The exemplified neutrophil shows that once the cell has breached an EC junction, the leading body part in the sub-EC space rapidly becomes AF647-Strept + whilst the luminal body segment remains AF647-Strept -. The AF647-Strept + neutrophil can be easily tracked as it migrates in a reverse manner towards the vascular lumen and re-enters the blood stream. Luminal and cross-sectional views are shown with the arrows indicating the direction of motility of the indicated neutrophil. Scale bars, 3m. (D) Fluorescence intensity of AF647-streptavidin on neutrophils in the venular lumen, tissue and cells exhibiting rTEM (n=4 mice/group) during an IL-1+histamine reaction. Data are represented as mean±SEM (each dot represents one mouse/independent experiment). Statistically significant differences from luminal neutrophils is shown by **p<0.01,***p<0.001, one-way ANOVA followed by Bonferroni's post-hoc test. Figure 9 . Accumulation of labelled rTEM neutrophils in lungs is linked with lung injury. The cremaster muscles of LysM-EGFP-ki mice were locally stimulated with IL-1 or PBS (2h). Mice were injected i.v. with AF555-anti-CD31 mAb (10g), biotin-anti-Ly6G mAb and fluorescent microspheres (20nm diameter, 9.1x10 13 beads) at t=90min to label the vasculature, neutrophils and to quantify vascular leakage, respectively. To induce and to track rTEM neutrophils stemming from the cremaster muscles, tissues were additionally stimulated with locally applied histamine or vehicle (PBS) in combination with Atto425-Streptavidin (AT425-Strept, 400ng) for 120min. The lungs were then analysed by confocal microscopy. (A) Representative confocal images of alveolar capillaries in wholemount imaged lungs of mice in which the cremaster muscles were locally stimulated as indicated (CD31-labelled vessels, red; neutrophils, blue; extravascular beads, green). Scale bars, 20m. (B) Lung vascular leakage as quantified by accumulation (MFI) of extravascular beads (n=4-6 mice/group) and (C) number of AT425-Strept + neutrophils per field of view (n=4-6 mice per group), in mice subjected to indicated cremaster muscle stimulations. (D) Correlation of the number of AT425-Strept + neutrophils and extravascular beads in lung tissues (n=4-6 mice/group). Line indicated linear regression and dashed lines 95% confidence band (Spearman r=0.7). (E) High magnification images of lung sections showing AT425-Strept + neutrophils in close apposition to sites of extravascular fluorescent bead accumulation. Scale bars, 3m. (F) Lung vascular leakage in close proximity (<60m) of AT425-Streptneutrophils or AT425-Strept + neutrophils (n=6 mice/group). Data are represented as mean±SEM (each dot represents one mouse/independent experiment). Statistically significant differences from PBS or indicated group are shown by **p<0.01,***p<0.001, and between indicated groups by ##p<0.01,###p<0.01, one-way ANOVA followed by Bonferroni's post-hoc test or paired t-test or Spearman's rank correlation test (ns=not significant). 
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